Prestige Consumer Healthcare Inc. (PBH) Analysts See $0.80 EPS

Prestige Consumer Healthcare Inc. (NYSE:PBH) Logo
Investors sentiment decreased to 0.94 in 2018 Q3. Its down 0.78, from 1.72 in 2018Q2. It is negative, as 21 investors sold Prestige Consumer Healthcare Inc. shares while 73 reduced holdings. 27 funds opened positions while 61 raised stakes. 62.29 million shares or 1.22% more from 61.54 million shares in 2018Q2 were reported.
Paloma Partners Mgmt reported 0.01% of its portfolio in Prestige Consumer Healthcare Inc. (NYSE:PBH). State Street owns 2.20 million shares. New York-based Manor Road Cap Limited Liability Corporation has invested 0.19% in Prestige Consumer Healthcare Inc. (NYSE:PBH). Tiaa Cref Investment Mngmt Lc reported 185,243 shares stake. Price T Rowe Associate Inc Md holds 0.01% in Prestige Consumer Healthcare Inc. (NYSE:PBH) or 2.41M shares. Voya Invest Management Ltd Liability Com reported 21,118 shares or 0% of all its holdings. Thrivent Fincl For Lutherans holds 0% or 12,790 shares. Captrust Financial Advsr has invested 0% in Prestige Consumer Healthcare Inc. (NYSE:PBH). Northwestern Mutual Wealth Mgmt holds 0% or 583 shares. Great West Life Assurance Company Can invested in 29,049 shares. Missouri-based Century Cos has invested 0% in Prestige Consumer Healthcare Inc. (NYSE:PBH). Regions Fincl Corp reported 0% in Prestige Consumer Healthcare Inc. (NYSE:PBH). Moreover, State Board Of Administration Of Florida Retirement Sys has 0% invested in Prestige Consumer Healthcare Inc. (NYSE:PBH) for 30,263 shares. Grp Inc has invested 0.02% in Prestige Consumer Healthcare Inc. (NYSE:PBH). California-based Rice Hall James has invested 0.15% in Prestige Consumer Healthcare Inc. (NYSE:PBH).

Analysts expect Prestige Consumer Healthcare Inc. (NYSE:PBH) to report $0.80 EPS on February, 7.They anticipate $0.10 EPS change or 14.29 % from last quarter’s $0.7 EPS. PBH’s profit would be $41.40M giving it 9.81 P/E if the $0.80 EPS is correct. After having $0.65 EPS previously, Prestige Consumer Healthcare Inc.’s analysts see 23.08 % EPS growth. The stock increased 0.67% or $0.21 during the last trading session, reaching $31.38. About 221,429 shares traded. Prestige Consumer Healthcare Inc. (NYSE:PBH) has declined 26.53% since January 12, 2018 and is downtrending. It has underperformed by 26.53% the S&P500.

Prestige Brands Holdings, Inc., through its subsidiaries, markets, sells, makes, and distributes over-the-counter healthcare and household cleaning products in North America, Australia, and internationally. The company has market cap of $1.62 billion. It operates through North American OTC Healthcare, International OTC Healthcare, and Household Cleaning divisions. It has a 4.89 P/E ratio. The company??s OTC healthcare products include Chloraseptic sore throat treatments and mouth pain products, Clear Eyes eye care products, Compound W wart removers, Dramamine Non-Drowsy naturals, Efferdent denture cleansers, Luden's throat drops, BC and Goody's analgesic powders, Beano for gas prevention, Debrox for ear wax removal, and Gaviscon for upset stomach remedies.

More notable recent Prestige Consumer Healthcare Inc. (NYSE:PBH) news were published by: which released: “Prestige Brands Is Down 42%, Is Now The Time To Buy? – Seeking Alpha” on March 28, 2018, also with their article: “Prestige Consumer Healthcare Inc. to Release Fiscal 2019 Second Quarter Earnings Results – GlobeNewswire” published on October 02, 2018, published: “Prestige Brands Holdings (PBH) Q1 2019 Results – Earnings Call Transcript – Seeking Alpha” on August 02, 2018. More interesting news about Prestige Consumer Healthcare Inc. (NYSE:PBH) were released by: and their article: “Prestige Brands Holdings (PBH) Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” published on May 10, 2018 as well as‘s news article titled: “Prestige Consumer Holdings (PBH) Presents At Barclays Global Consumer Staples Conference – Slideshow – Seeking Alpha” with publication date: September 06, 2018.

Prestige Consumer Healthcare Inc. (NYSE:PBH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.